An Improved 2-Aminoimidazole Based Anti-Biofilm Coating for Orthopedic Implants: Activity, Stability, and in vivo Biocompatibility
Open Access
- 21 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12
Abstract
Orthopedic device-related infections remain a serious challenge to treat. Central to these infections are bacterial biofilms that form on the orthopedic implant itself. These biofilms shield the bacteria from the host immune system and most common antibiotic drugs, which renders them essentially antibiotic-tolerant. There is an urgent clinical need for novel strategies to prevent these serious infections that do not involve conventional antibiotics. Recently, a novel antibiofilm coating for titanium surfaces was developed based on 5-(4-bromophenyl)-N-cyclopentyl-1-octyl-1H-imidazol-2-amine as an active biofilm inhibitor. In the current study we present an optimized coating protocol that allowed for a 5-fold higher load of this active compound, whilst shortening the manufacturing process. When applied to titanium disks, the newly optimized coating was resilient to the most common sterilization procedures and it induced a 1 log reduction in biofilm cells of a clinical Staphylococcus aureus isolate (JAR060131) in vitro, without affecting the planktonic phase. Moreover, the antibiofilm effect of the coating in combination with the antibiotic cefuroxime was higher than cefuroxime treatment alone. Furthermore, the coating was successfully applied to a human-scale fracture fixation device resulting in a loading that was comparable to the titanium disk model. Finally, an in vivo biocompatibility and healing study in a rabbit osteotomy model indicated that these coated implants did not negatively affect fracture healing or osteointegration. These findings put our technology one step closer to clinical trials, confirming its potential in fighting orthopedic infections without compromising healing.Keywords
Funding Information
- KU Leuven (C32/17/020, STG/17/024)
- Fonds Wetenschappelijk Onderzoek (S007019N, 3G046318)
- RUDN University (Program 5-100)
This publication has 26 references indexed in Scilit:
- Bioactive Coatings for Orthopaedic Implants—Recent Trends in Development of Implant CoatingsInternational Journal of Molecular Sciences, 2014
- A GFP promoter fusion library for the study ofSalmonellabiofilm formation and the mode of action of biofilm inhibitorsBiofouling, 2014
- Prosthetic Joint InfectionClinical Microbiology Reviews, 2014
- Targeting virulence: can we make evolution-proof drugs?Nature Reviews Microbiology, 2014
- Prevalence of complications of open tibial shaft fractures stratified as per the Gustilo–Anderson classificationInjury, 2011
- How To Prepare Reproducible, Homogeneous, and Hydrolytically Stable Aminosilane-Derived Layers on SilicaLangmuir, 2011
- Staphylococcus aureus Biofilms Prevent Macrophage Phagocytosis and Attenuate Inflammation In VivoThe Journal of Immunology, 2011
- Selective Advantage of Resistant Strains at Trace Levels of Antibiotics: a Simple and Ultrasensitive Color Test for Detection of Antibiotics and Genotoxic AgentsAntimicrobial Agents and Chemotherapy, 2011
- Biocompatibility Issues with Modern Implants in Bone - A Review for Clinical OrthopedicsThe Open Orthopaedics Journal, 2008
- Determining the Capability of a Drug Product to Be Terminally Sterilized: A Case Study Involving a Heat-Sensitive, Oxygen-Sensitive Drug ProductPharmaceutical Development and Technology, 1998